Table 4

Percentage and number of respondents by case and rank for both case notes and COR

Hypothetical caseCOROrder of preference with case notes given, % (number of participants); n=148Order of preference with COR only, % (number of participants); n=126
FirstSecondThirdFourthFifthFirstSecondThirdFourthFifth
AWoman in her late 70s with a nuclear cataract in the right eye.
PMH: glaucoma.
Medication: Lumigan 1 drop BE ON.
Axial length: 23.68 mm.
Pupil size: large.
1.8429.73
(44)
31.08
(46)
14.86
(22)
16.89
(25)
7.43
(11)
20.63
(26)
42.86
(54)
3.97
(5)
19.05
(24)
13.49
(17)
BWoman in her late 50s with a nuclear cataract in the right eye.
PMH: no other ophthalmic or medical history.
Medication: nil regular.
Axial length: 24.25 mm.
Pupil size: large.
1.039.86
(59)
20.95
(31)
7.43
(11)
4.05
(6)
27.70
(41)
53.97
(68)
3.17
(4)
3.97
(5)
7.94
(10)
30.95
(39)
CMan in his late 60s with a nuclear cataract in the right eye.
PMH: pseudoexfoliation syndrome, hypertension.
Medication: amlodipine 5 mg OD, simvastatin 40 mg ON.
Axial length: 26.1 mm.
Pupil size: medium.
7.146.08
(9)
13.51
(20)
33.78
(50)
33.11
(49)
13.51
(20)
0.79
(1)
20.63
(26)
17.46
(22)
49.20
(62)
11.90
(15)
DMan in his early 90s with a brunescent cataract and no fundal view in the right eye. Due to heart disease he is unable to lie flat.
PMH: hypertension, benign prostatic hypertrophy, mild left ventricular failure.
Medications: atorvastatin 40 mg ON, bisoprolol 7.5 mg OD, doxazosin MR 8 mg OD, ramipril 2.5 mg OD, furosemide 40 mg OD.
Axial length: 23.72 mm.
Pupil size: large.
42.7919.59
(29)
20.95
(31)
10.81
(16)
16.22
(24)
32.43
(48)
18.25
(23)
15.87
(20)
21.43
(27)
9.52
(12)
34.92
(44)
EMan in his early 80s with a nuclear cataract in the right eye.
PMH: glaucoma.
Medication: Lumigan 1 drop BE ON.
Axial length: 20.8 mm.
Pupil size: large.
2.634.73
(7)
13.51
(20)
33.11
(49)
29.73
(44)
18.92 (28)6.35
(8)
17.46
(22)
53.17
(67)
14.29
(18)
8.73
(11)
  • BE, Both eyes; COR, composite OR; MR, Modified Release; OD, Once a day; ON, Once at night; PMH, Past Medical History.